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CHAPTER 12A 
Summary 
This thesis presents the results of a study on the role and function of vascular endo- 
thelial cells in immune responses. 
In section 'Introduction' an overview olf isnmu~~e reactions involved in allograft rejec- 
tion is presented. The succeeding events in immune processes can be described as fol- 
lows: Antigen is taken up by antigen presenting cells, processed in these cells, and ex- 
pressed on the cell membrane in association with MHC-class 11 antigens. Helper T 
lymphocytes recognize the complex of antigen and MHC-class I1 antigens and are acti- 
vated by the APC-released 11-1. T helper cells release lymphokines, among them 11-2, 
after activation. Precursors of cytstotoxic T lymphocytes recognize antigen in associati- 
on with MHC-class I antigen and are activated by 11-1. Upon activation, the CTL ac- 
quire receptors for the T cell growth factor 11-2 and start to proliferate to achieve ex- 
pansion of the effector cell population. Adifferent mode of T cell activation occurs in 
allograft reactions. In an allograft specialized cells from the donor present their own 
alloantigens lo T lymphocytes of the recipient, which are thereby activated. 
In section Yntroduction to the experiments', it is indicated in which events the puta- 
tive role and function of endothelial cells have been studied. 
Chapter 3 describes the technique of culture of endothelid cells in vitro. The target 
determinants recognized by CTL, generated in MLC, on arterial and venous endo- 
thelid cells and lyrnphoblasts are compared in cold target inhibition experiments. 
It is concluded that these CTL recognize similar determinants on AEC and lympko- 
blasts, and different determinants on WEC and lymphoblasts. 
Chapter 4 describes a procedure for cloning of canine CTL, generated in mixed 
]lymphocyte cultures. The patterns of cytolysis of lyrnphoblasts, monocyres and 
AEC and VEC have been determined. A limited number of patterns of lysis of one 
or more than one of these Four different targets has been observed. These data sug- 
gest the existence of a number of alloantigen systems with a wide or with a limited 
distribution over the used targe.t cells. 
Chapter 5 describes the effects of lymphokines on the morphology and motility of 
endothelial cells. In a species specific action lymphokines other than Interleukin 2 
and interferon gamma affect the morphology of canine and human endothelial cells 
and increase their mobility. 
Chapter 6 describes the stimulation of lymphocytes by allogeneic endothelial cells. 
It. is observed that allogeneic endothelial cells induce proliferation of lymphocytes. 
PllEC generate CTL agdnst AEC and lymphoblasts, while VEC generate CTL 
against AEC, VEC and lymphoblasts. It is concluded, in relation to the finding in 
chapter 3, that different determinants are: recognized on AEC and YEC, in both Ithe 
generation phase and in the effector phase of cell-mediated cytotoxiciby. 
Chapter 7 describes a method to deplete suspensions of canine peripheral blood leu- 
kocytes of antigen presenting cells, and thereby isolate purified populations of lym- 
phocytes. This method is used to study the capacity of endothelid cells to present 
alloantigens to unprirned syngeneic lymphocytes in support of proliferation of these 
lymphocytes and of generation of CTL. It appears that both AEC and VEC can pre- 
sent allaantigens in this system, resulting in proliferation and differentiation of 
lymphocytes in MLC. Endothelial cells of the recipient would therefore be able to 
present donlor alloantigens shed from an allograft to recipient lymphocytes. 
Chapter 8 describes experiments to study the capacity of endothelial cells to stimula- 
te allogerreic lymphaicytes without the need for additional antigen presenting cells. 
The experiments indicate that venous endothelial cells are capable of self-alloantigen 
presentation. Pt is concluded that donor endothelial cells can be jrnpordarrt in the ini- 
tial phase of rejection of vascwlarized allografts because of their capacity to present 
donor self-allaantigens to recipient lymphocytes. 
Chapter 9 and 10 describe the expression of MHC-class I1 antigens by endothelial 
cells. Lymphokines were observed to induce the expression of these antigens in vi- 
tro. The secretion of these lymphokines is inhibited by cyclosporin A (chapter 9). 
The expression, of MHC-class II antigens on endothelial cells in vivo is absent during 
treatment of dogs with cycllosporin A in vjvo. It is concluded in chapter 10 that the 
antigen expression by endothelial cells is not a constitutive property of these cdls, 
but is dependent on lymphokines. 
In section 'General discussion of the experiments' an overview is presented of the 
roles and functions of endotheliar1 cells in immune reactions that have been studied. 
MMC-class I1 antigen expression in vjltro and in vivo, bath dependent on lyrnphoki- 
nes, allow a regulatory function in immunological processes. Endothelial cells sti- 
mulate the generation of CTL. CTL recognize different determinants on AEC and 
VEC, demonstrated at the cIonal level of CTL. Endothelial cells are lysed by CTL 
and affected by lymphokines. In conclusion: endothelial cells have essential functi- 
ons in immunological reactions leading to allograft rejection. 
Iw dit proefschrift worden de resultaten gepresentecrd van eon onderzoek naar de 
rol en functie van vasculairc endotheelcellen in immunologische reacties. 
En "ntroduction' wordt een overzicht gegeven van imrnunologische reacties die be- 
trokken zijn bij afstoting van getransplanreerde organen. De opeenvolgende gebeur- 
tenisscn daarbij wordesr beschreven: arrtigeen wordt opgenomen door een antigeen 
presenterende cel, in deze ceY verwerkt en daarna a p  de celrnembraan gepresenreerd 
in samenhang rncd MHC-klasse I1 antigenen. T-lymfocyten met hulp-functie herken- 
nen dit complex van antigeen en MHC-class 11 anligeen en worden geactiveerd door 
11-1 wat vrijgemaakt wordt door de antigeen presenterende cellen. Hwlp T-cellen 
scheiden na activatie lyrnfokinen, waaronder 11-2, uit. Voorlopers van cytotoxische 
T-lyrnfocyten herkennen het antigeen in samenhang met MHC-klasse I antigenerr en 
worden geactiveerd door 11-1. Tljdens activatie krijgen CTL receptoren voor de T- 
cel groeifactor 11-2 en door proliferatie wordt ale effector ccl populatie vergroot. Tij- 
dens reacties tegen een transplantaat worden T lyrnfocyten op een andere wijze geac- 
tiveerd: in een transplantaat presenteren gespecialiseerde cellen hun eigerv lichaams- 
vreemde antigeen aan T lymfocyten van de transplantaat-ontvai~ger, waardoor de 
T lymfocyten geactiveerd worden. 
In 'Introduction to the experiments' is aangegeven in welke gebeurtenissen de rnoge- 
lijhe rol en functie van endatheelcellen is bestudeerd. 
'Chapter 3' beschrijft de technick van het kweken van endotheelcellen in vitro. In 
'cold target inhibition' experimenten worderr de determinanten die in MLC gegene- 
reerde CTL herkennen op arteriele en veneuze endolheelcellen en Pymfoblasten ver- 
geleken. De uitkomsten van de experirnenten geven aan dat CTL gelijke deterrninan- 
ten herkennen op AEC en lymfoblasten en verschillende deterrninall~ren op VEC en 
lyrnfoblasten. 
'Chapter 4' beschrijft een methode voor het kloneren van CTL tail MLC van de 
hond. De patronen van cytolysis van llymfoblasten, rnonocyten, AEC en VEC wer- 
den bepaald. Een beperkt aantal patronen van lysis van een of mecr verschillendc 
cellen werd waargenomen. Die uitkomsten suggereren het bestaan van een aantan 
systemen van lichaamsvreernde antigenen met een beperkte of met een mime ver- 
spreiding over de gebruikte cellen. 
'Chapter 5' beschrijft het effect van lymfokinen op de worm en beweeglijkheid van 
endotheelcellen. Lyrnfokinen anders dan 11-2 en gamma interferon veroorzaken op 
een species-specifieke wijze verandering in de vorm van de endotheellcellen van mens 
en hond en een verhoogde beweeglijkheid van deze cellen. 
'Chapter 6' beschrijft dl: stimulatie van lymfocyten door liclnaamsvreemde endo- 
theelcellen: deze endotheelcellen veroiarzaken proliferarie van lymfocyten. AEC ge- 

